Advanced search
Publication Cover
Infectious Diseases Volume 49, 2017 - Issue 3
Submit an article Journal homepage
131
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful management of methicillin-resistant Staphylococcus aureus bacteremia complicated with diffuse myelitis

Joy EduwuInternal Medicine Department, Texas Tech University, Health Sciences Center, Odessa, TX, USA
,
Fouzia TabasamMedical Center Hospital, Odessa, TX, USA
,
Alexander A. BastidasCritical care, Texas Tech University, Health Sciences Center, Odessa, TX, USA
,
Khavar DarPulmo-Critical Care, Texas Tech University, Health Sciences Center, Odessa, TX, USA
&
Yasir AhmedInfectious Diseases/Internal Medicine Department, Texas Tech University, Health Sciences Center, Odessa, TX, USACorrespondence[email protected]
Pages 234-236 | Received 11 Jun 2016, Accepted 26 Jun 2016, Published online: 27 Jul 2016

References

  • Arslan F, Yilmaz M, Paksoy Y, et al. Cytomegalovirus-associated transverse myelitis: a review of nine well-documented cases. Infect Dis (Lond). 2015;47:7–12.
  • Berman M, Feldman S, Alter M, et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981;31: 966–971.
  • Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol. 1993;50:532.
  • Borchers AT, Gershwin ME. Transverse myelitis. Autoimmun Rev. 2012;11:231–248.
  • Gokhan K, Abdulbaki K, Sebahattin V, et al. Methicillin resistant Staphylococcus aureus pneumonia accompanied with transverse myelitis. Eur J Gen Med. 2012;9:203–204.
  • Saini M, Prasad K, Ling LM, et al. Transverse myelitis due to Staphylococcal aureus may occur without a contigous spread. Spinal Cord. 2014;52:S1–S2.
  • Kern WV. Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis. 2010;23:346–358.
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:18–55.
  • Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother. 2007;60:788–794.
  • Kalil AC, Van Schooneveled TC, Fey PD, et al. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA. 2014;312:1552–1564.
  • Jacob JT, Diaz Granados CA. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis. 2013;17:e93–e100.
  • Davis JS, Van Hal S, Tong SYC. Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus Infection. Semin Respir Crit Care Med. 2015;36:3–16.
  • Parra-Ruiz J, Bravo-Molina A, Pena-Monje A, et al. Activity of linezolid and high dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm. J Antimicrob Chemother. 2012;67:2682–2685.
  • Kelesidis T, Humphries R, Ward K, et al. Combination therapy with daptomycin, linezolid and rifampin as treatment option for MRSA meningitis and Bacteremia. Diagn Microbiol Infect Dis. 2011;71:286–290.
  • Dhand A, Sakoulas G. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin resistant Staphylococcus aureus bacteremia. Clin Ther. 2014;36: 1303–1316.
  • Snydman DR, McDermott LA, Jacobus NV. Evaluation of in vitro interaction of daptomycin with gentamicin or beta lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed kill curves. J Chemother. 2005;17:614–621.
  • Jiang JH, Peleg AY. Daptomycin-nonsusceptible Staphylococcus aureus: the role of combination therapy with daptomycin and gentamicin. Genes [Basel]. 2015;6:1256–1267.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.